Ann Murphy
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 4
- CAR-T cell therapy research 3
- HER2/EGFR in Cancer Research 1
-
- Immunotherapy and Immune Responses 3
- Co-authors
- Mary L. DisisWei ChenEmanuel CalenoffBernd GronerRobert B. LivingstonElaine McGlynnMargit JeschkeJoseph Wayne Smith
- Journals
- Journal of Clinical Oncology (1 paper)Journal of Thoracic Oncology (1 paper)Cancer Research (1 paper)Immuno-Oncology Technology (1 paper)PubMed (2 papers)
- Partner nations
- United StatesSwitzerlandAustralia
In The Last Decade
Ann Murphy
6 papers receiving 544 citations
Peers
Comparison fields: 5 of 44
- Immunology 422
- Radiology, Nuclear Medicine and Imaging 249
- Oncology 257
- Molecular Biology 245
- Biotechnology 15
Countries citing papers authored by Ann Murphy
This map shows the geographic impact of Ann Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Murphy more than expected).
Fields of papers citing papers by Ann Murphy
This network shows the impact of papers produced by Ann Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Murphy. The network helps show where Ann Murphy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ann Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 29 | |
| 4 | 2021 | 1 | |
| 5 | Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. | 1994 | 390 |
| 6 | In vitro generation of human cytolytic T-cells specific for peptides derived from the HER-2/neu protooncogene protein. | 1994 | 129 |
About Ann Murphy
Ann Murphy is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Genetics and Hematology, having authored 6 papers that have together received 553 indexed citations. Recurring topics across this work include CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), HER2/EGFR in Cancer Research (1 paper), Glycosylation and Glycoproteins Research (1 paper), Radiomics and Machine Learning in Medical Imaging (1 paper), TGF-β signaling in diseases (1 paper) and Cancer-related molecular mechanisms research (1 paper). The work is most often cited by research in Immunology (422 citations), Radiology, Nuclear Medicine and Imaging (249 citations), Oncology (257 citations), Molecular Biology (245 citations) and Biotechnology (15 citations). Ann Murphy has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Mary L. Disis, Wei Chen, Emanuel Calenoff, Bernd Groner, Robert B. Livingston, Elaine McGlynn, Margit Jeschke, Wei Chen, Joseph Wayne Smith and Martin A. Cheever. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Cancer Research, Immuno-Oncology Technology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.